The cranial nerves are stabilised
during cranial stabilisation in preparation for brain surgery. Craniotomy is
another name for brain surgery. The type of brain issue determines whether a
craniotomy is necessary. The main purposes of this procedure are to help cure
brain tumours, hematomas (blood clots), aneurysms or arteriovenous
malformations (AVM), severe head injuries, foreign objects (bullets), brain
edoema, or infections.
During the course of the
projected period, it is anticipated that the incidence of neurological
illnesses would spur market expansion for cranial stabilising devices.
According to the 2015 Global Burden of Disease Survey, neurological illnesses
are the leading global cause of disability and fatality. Over the previous 25
years, from 1990 to 2015, the burden of neurological illnesses has grown by
36.7 percent.
The Cranial
Stabilization Devices Market Size, Share, Outlook, and Opportunity
Analysis, 2022-2028 is divided into North America, Latin America, Europe, Asia
Pacific, Middle East, and Africa on the basis of region.
The market size for cranial
stabilisation devices in the area is anticipated to be driven by rising merger
and acquisition activity in North America. For instance, Johnson &
Johnson's Codman Neurosurgery division was purchased by Integra LifeSciences
Holdings Company in October 2017. The Codman Neurosurgery company offers a
selection of equipment for cranial surgery, neurointensive care, and
hydrocephalus control. The transaction was completed for US$1.045 billion. Global
neurofeedback market is estimated to be valued at US$ 1,253.5 million
in 2023 and is expected to exhibit a CAGR of 7.3% during the forecast period
(2023-2030).
Due to increased efforts by
several organisations to support the development of clinical neurology and
neurological science in Asia Pacific, the region is also anticipated to
experience considerable growth in the cranial stabilisation devices market. For
instance, the Asian and Oceanian Association of Neurology (AOAN) organised the
conference The Asian Oceanian Congress of Neurology 2018 (AOCN 2018) in
November 2018 to give attendees (neurologists) an unmatched understanding of
the most recent research, developments, and treatments in the field of
neurosciences through its extensive scientific programme led by local neurology
experts.
Integra Lifesciences Holdings
Corporation, Jintan Huida Medical Instrument Co. Ltd., B. Braun Melsungen AG,
DePuy Synthes, evonos GmbH & Co. KG, Jeil Medical Corporation, Medtronic,
Micromar, NEOS Surgery, OsteoMed, Pro Med Instruments, Stryker, and Zimmer
Biomet are some of the major companies in the cranial stabilisation devices
market.
Comments
Post a Comment